Hairy-cell leukemia (HCL) is a rare, indolent neoplasm of mature B cells with hairlike surface projections that circulate in the blood and preferentially infiltrate the bone marrow and spleen. The ...

CURE sat down with Dr. Kerry A. Rogers for an interview at the Hairy Cell Leukemia Foundation 2025 Conference, hosted in Bologna, Italy. We sat down with Dr. Kerry A. Rogers for an interview at the ...

Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in ...

Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in ...

The stage of a cancer means how far it has developed. Most types of cancer have a staging system. For example, a number stage system from 1 to 4. But this is not really used for hairy cell leukaemia.

There are different treatment options for hairy cell leukaemia. The main treatment is chemotherapy. Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. It is the main treatment ...

NOTE. The Involvement row lists measurable sites of HCL/HCLv outside the bone marrow, which also constituted indications for treatment. Mutations were determined by TSO500 NGS of 523 genes. VAF are ...

Combination Therapy With Olaparib Plus Lenvatinib in a Patient With BRCA2-Mutated, Radioiodine-Refractory, Metastatic Papillary Thyroid Cancer: A Case Report The following represents disclosure ...

Hairy cell leukaemia (HCL) remains an intriguing B‐cell malignancy defined by its distinctive “hairy” cytoplasmic projections and its unique pattern of bone marrow infiltration. Recent research has ...